FDA clears Siemens’ sliding gantry CT

Article

Siemens announced that it has Food and Drug Administration approval for a sliding gantry version of its Somatom Plus 4 CT system, which can be set up in a radiation therapy treatment room to give almost-real-time images to the radiation

Siemens announced that it has Food and Drug Administration approval for a sliding gantry version of its Somatom Plus 4 CT system, which can be set up in a radiation therapy treatment room to give almost-real-time images to the radiation oncologist.

Designed to be used in conjunction with a linear accelerator, the scanner images a patient lying on the treatment table by having the gantry make incremental movements during the scanning process rather than having the table turn, as in a traditional CT setting.

“The advantage in having the CT close to the (radiation) delivery machine is that you don’t have to reposition the patient (for therapy),” said Mark McCarthy, senior product manager in Siemens Oncology Care Systems.

Based on tumor localization data from the scan, the linear accelerator can then almost immediately deliver optimal radiation therapy to the tumor while sparing maximal normal tissue.

Until now, the patient typically was scanned some time—perhaps days—before actual therapy, McCarthy said, making it impossible to position the patient in precisely the same location and attitude for therapy. In addition, the tumor may have changed size or position since it was imaged and the patient may have gained or lost weight, all of which detract from accurate treatment.

“In theory, this allows you to know where the target is the moment before treatment,” McCarthy said. Depending on equipment availability, scans could be repeated at the time of each treatment.

Siemens is installing the combination Somatom Plus 4 with sliding gantry and its Primus linear accelerator at Morristown Memorial Hospital in Morristown, NJ. The project is a collaboration with Dr. James Wong, the hospital’s chairman of radiation oncology, and Dr. Minoru Uematsu of the National Defense Medical College in Saitama, Japan.

Now that they have the hardware, the collaborators’ next goal is to develop a digital interface that will allow automatic targeting of the linear accelerator.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.